Skip to main content
. 2016 Jun 15;193(12):1392–1400. doi: 10.1164/rccm.201508-1522OC

Table 1.

Characteristics of the Cohort (N = 117) Stratified by Primary Graft Dysfunction Status

Covariate PGD (n = 30) Non-PGD (n = 87) P Value
Donor characteristics      
 Smoke exposure, n (%) 7 (28.0) (n = 25) 12 (16.0) (n = 75) 0.19
 Cause of death, n (%) n = 27 n = 75 0.06
  Head trauma 12 (44.4) 27 (36.0)  
  Anoxia 0 (0.0) 16 (21.3)  
  Stroke 12 (44.4) 28 (37.3)  
  Other 3 (11.1) 4 (5.3)  
Recipient characteristics      
 Age, yr 58.0 [52.2–60.5] 56.5 [49.5–60.5] 0.60
 Male sex, n (%) 20 (66.7) 56 (64.4) 0.82
 Race/ethnicity, n (%)     0.14
  Caucasian 22 (73.3) 75 (86.2)  
  African American 7 (23.3) 8 (9.2)  
  Other 1 (3.3) 4 (4.6)  
 Body mass index, kg/m2 29.7 ± 5.0 26.6 ± 4.9 0.004
 History of hypertension, n (%) 15 (50.0) 26 (29.9) 0.05
 Use of antihypertensive or diuretic, n (%) 19 (63.3) 30 (34.5) 0.006
 History of diabetes, n (%) 6 (20.0) 12 (13.8) 0.42
 History of coronary artery disease, n (%) 11 (36.7) 32 (36.8) 0.99
 History of obstructive sleep apnea, n (%) 4 (13.3) 9 (10.3) 0.65
 Supplemental O2 with exertion, L 10 [6–100] 5.5 [3–10] (n = 86) 0.009
 Six-minute walk distance, ft 965.8 ± 278.8 1046.4 ± 351.3 (n = 86) 0.26
 Pretransplant diagnosis, n (%)     0.001
  Chronic obstructive pulmonary disease 6 (20.0) 49 (56.3)  
  Interstitial lung disease 19 (63.3) 35 (40.2)  
  Pulmonary arterial hypertension 5 (16.7) 3 (3.5)  
 Pulmonary function tests      
  FVC, % predicted 49 [40–73] 51 [42–63] (n = 86) 0.83
  FEV1, % predicted 46.5 [31–63] 29.5 [17–50] (n = 86) 0.003
  FEV1/FVC 84 [56–86] 38 [26–85] 0.02
  TLC, % predicted 75 [54–110] (n = 26) 100 [58–125] (n = 69) 0.10
  DlCO, % predicted 30.5 [21–38.5] (n = 16) 34 [27–47] (n = 49) 0.18

Definition of abbreviations: DlCO = diffusing capacity of the lung for carbon monoxide; PGD = primary graft dysfunction; TLC = total lung capacity.

Data are given as mean ± SD, median [interquartile range], or n (%).